Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 1,649 | 1,196 | 27,859 | 1,858 | 2,542 |
| Gross Profit | 1,649 | 1,196 | 27,859 | N/A | 2,542 |
| Operating Expenses | 5,827 | 5,197 | 5,950 | 0 | 6,070 |
| Operating Income | -4,178 | -4,001 | 21,909 | -4,096 | -3,528 |
| Interest Expense | 7 | 9 | 7 | 0 | 0 |
| Other Income | 47 | 261 | 55 | 4,096 | 27 |
| Pre-tax Income | -4,138 | -3,749 | 21,957 | 0 | -3,501 |
| Net Income Continuous | -4,138 | -3,749 | 21,957 | N/A | -3,501 |
| Net Income | $-4,138 | $-3,749 | $21,957 | $N/A | $-3,501 |
| EPS Basic Total Ops | -0.23 | -2.28 | 1.61 | -4.78 | -4.31 |
| EPS Basic Continuous Ops | -0.23 | -1.71 | 18.96 | N/A | -3.13 |
| EPS Diluted Total Ops | -0.23 | -2.28 | 1.45 | -4.78 | -4.31 |
| EPS Diluted Continuous Ops | -0.23 | -1.71 | 8.33 | N/A | -3.13 |
| EBITDA(a) | $-3,821 | $-3,756 | $22,152 | $2,124 | $-3,258 |